Alex Bastian | Vice President, Commercial Strategy
Memo Therapeutics

Alex is Vice President of Commercial Strategy & Market Access at Memo Therapeutics. He is a serial biotech leader that has previously held roles at companies, such as AM-Pharma, Galapagos, and Incyte. He started his career with pharmaceutical heavyweights such as Pfizer and Amgen. He holds an MBA from IESE Business School. Alex current sits on the editorial advisory board for the Journal of Comparative Effectiveness Research and is completing his doctorate in public health at Johns Hopkins University